Introduction
A sbestos exposure can be responsible for non-malignant diseases such as pleural plaques and asbestosis as well as malignant diseases, mainly mesothelioma and lung cancer. [1] [2] [3] [4] The incidence of these diseases is clearly related to the intensity of asbestos exposure and the time since onset of exposure. [5] [6] [7] Asbestosis is well known to be an independent risk factor for lung cancer. 8 Smokers with rapid progression of asbestosis are at higher risk of developing lung cancer. 9 It has also recently been suggested that pleural plaques are independent risk factors for lung and pleural cancers. 10, 11 Finally, it has been proposed that time and dose parameters should be included in the definition of the high-risk population requiring asbestos-related disease screening. 7 Moreover, if the impact of real risk as the likelihood that an individual can experience the effect of danger is very important on health, 12 ,13 risk perception is also crucial to explain attitudes and behaviours. [14] [15] [16] Risk perception is the subjective assessment of the probability of a specified type of accident happening and how concerned we are with the consequences. To perceive risk includes evaluations of the probability as well as the consequences of a negative outcome. It may also be argued that an effect related to the activity is an element of risk perception. Perception of risk goes beyond the individual, and it is a social and cultural construct reflecting values, symbols, history and ideology. [16] [17] [18] [19] In this case, uncertainty is closely related to risk perception 20, 21 and psychological uncertainty is assumed to be an important mediator of human responses in situations with unknown outcomes. [22] [23] [24] Uncertainty is a psychological construct. It 'exists only in the mind; if a person's knowledge was complete, that person would have no uncertainty ' . 21 Risk appears to mean different things to different people and actions and understandings about risks are learned by socially and culturally structured conceptions and evaluations. 25 However, little attention has been paid to the potential psychological effects of asbestos exposure, asbestos-related diseases or periodic screening programs for asbestos-exposed subjects. For instance, the diagnosis of mesothelioma among co-workers has been associated with post-traumatic stress disorder. 26 Lebovits has reported profound changes of self-perception of health status among asbestos-exposed subjects, regardless of their clinical condition. 27 We have previously reported that, at baseline of the French asbestos-related diseases CT screening program, namely the Asbestos Post-Exposure Survey (APExS), a significantly higher level of psychological distress was observed among exposed subjects compared with the non-exposed reference group. This distress was independently associated with the self-perception of intensity of asbestos exposure and self-perception of current or future asbestos-related diseases. 28 It should be noted that, in this study, distress was assessed by a validated scale used in breast cancer screening programs. 29 Finally, only a few psychological distress studies among asbestos-exposed workers have been published, and none of them used specific and widely validated scales of distress assessment such as the HADS tool. Consequently, the potential psychological impact of occupational asbestos exposure and the underlying mechanisms remain controversial.
The objectives of this study were to estimate the prevalence of anxious and depressive symptoms among participants of the French asbestos-related diseases CT screening program 6 years after their inclusion in the cohort; to identify the risk factors associated with those symptoms and to evaluate the impact of the asbestos-risk perception.
Methods

Study participants
The overall design of this study has been previously published. 7 Briefly, a large-scale screening program for asbestos-related diseases was organised in four regions of France (Aquitaine, Rhone-Alpes, Basse-Normandie and Haute-Normandie) between October 2003 and December 2005. A total of 16 885 unemployed or retired asbestos-exposed workers covered by French National Health Insurance were included at baseline and 6546 (38.8%) subjects were assessed by CT scan (figure 1). Between 2007 and 2009, they constitute the Asbestos-Related Diseases Cohort (ARDCO) and they were followed up in ARDCO I study: available CT scan CD-ROMs of participants (n = 5825) were systematically and independently reviewed by two of the panel of seven chest radiology experts. 30 Between 2011 and 2012 (ARDCO II study), subjects who were still alive and in whom the CT scan was reviewed in 2007-2009, were invited to undergo another chest CT scan 6 years after the previous CT scan. All voluntary participants to a follow-up CT scan were included in this study.
Instruments and assessment
A self-administered questionnaire was sent to the participants together with the invitation to undergo another CT scan. Their asbestos-risk perception, self-perception of current and future asbestos related diseases were assessed by using the same questions than previously published. 28 The asbestos exposure was first selfevaluated by the participants and secondly re-evaluated by the industrial hygienists (experts). Anxious and depressive symptoms were assessed using the French version of the Hospital Anxiety and Depression Scale (HADS). 31 The HADS was constructed in 1983 to allow a rapid and separate measure of depression and generalised anxiety in hospital, outpatient and community settings, and it is also widely used in research settings. 31, 32 The HADS was found to perform well in assessing the symptom severity and caseness of anxiety disorders and depression in both somatic, psychiatric and primary care patients and in the general population. 33 The HADS is used to assess the presence and severity of anxious and depressive symptoms rather than distinguish between the various types of anxiety or depression. The HADS is a self-administered rating scale that produces an Anxiety subscale (HADS-A) and a Depression subscale (HADS-D) both containing seven intermingled items.
The HADS-A and HADS-D subscales are scored from 0 to 3 (4-point Likert scales), giving maximum scores of 21 for anxiety and depression, respectively.
The project was approved by the Cochin Hospital ethics committee in Paris and all participants received information about the study and provided their informed consent.
Statistical analysis
All participants who returned completed questionnaires were included in the present analysis. The HADS-A and HADS-D subscales were calculated by summing the scores for the responses for anxiety and depression items, respectively. According to the classification proposed by Snaith, 34 a score of 0-7 for either subscale could be regarded as being in the 'normal range' (no symptom of anxiety/depression), a score of 11 or higher indicating presence of symptoms of probable anxiety/depression and a score of 8-10 being just suggestive of the presence of the respective state (symptoms of suggestive anxiety/depression).
Socio-demographic indicators and others general characteristics of the study population were first described. Secondly, socio-demographic indicators, general characteristics of the study population, the intensity of asbestos exposure, variables of asbestos-risk perception and self-perception of asbestos-related diseases were compared across HADS-A or HADS-D subscale score using the chi-squared statistic.
Generalised logistic regression models, with stepwise selection, were used to assess the association between each risk factor previously selected by the chi-square and the odds of developing anxious and depressive symptoms, respectively. We performed two separate generalised logistic regression models, one with selfperception of current asbestos-related diseases (model 1) and the other with self-perception of future asbestos-related diseases (model 2). These two models were systematically adjusted for age, gender, last job category in career, smoking status and region of recruitment.
Data were analyzed by SAS software (SAS Institute, release 9.3).
Results
For the 2011-2012 campaign (ARDCO II), 4339 participants were eligible for a second CT scan (figure 1), 2225 (51.3%) of them returned their questionnaires and 2210 fully completed the HADS (missing data = 0.67%). Characteristics of study participants and non-participants at inclusion in the cohort are provided in Supplementary table S1.
The mean age of the study participants was 69.8 years (SD 5.4), 95.9% (n = 2133) were males, 3.7% (n = 81) were current smokers (Supplementary tables S1 and S2). The prevalence of symptoms of probable anxiety and depression was 19.7% (n = 435) and 9.9% (n = 219), respectively, among the 2210 participants included in the analysis (Supplementary table S2) . Table 1 shows that the prevalence of symptoms of probable anxiety was significantly different between the three French regions (23.7% in Normandie, 16 .8% in Aquitaine and 17.9% in Rhô ne-Alpes, P = 0.0007). Women had significantly more anxious symptoms than men (34.8%, P < 0.0001) and the HADS-A subscale score was significantly associated to the intensity of asbestosexposure self-evaluated (P < 0.0001), but not to expert assessment (P = 0.19) (table 1). HADS-A subscale score was also significantly associated to all variables of asbestos-risk perception and selfperception of asbestos-related diseases (table 1) .
In table 2, the HADS-D subscale score was still significantly associated to the intensity of asbestos-exposure self-evaluated (P < 0.0001), but not to expert assessment (P = 0.088). Women had significantly more depressive symptoms than men (18.5%, P < 0.0001) and HADS-D subscale score was also significantly associated to all variables of asbestos-risk perception and selfperception of asbestos-related diseases (table 2) .
For presentation purposes, the odds ratio of developing symptoms of probable anxiety and depression, vs. normal range of HADS-A and HADS-D subscales scores, respectively, are shown in table 3; including 'self-perception of current asbestos-related diseases' (model 1) and 'self-perception of future asbestos-related diseases' (model 2). In model 1, self-assessment of the intensity of asbestos exposure, opinions that 'all subjects exposed to asbestos will develop a disease' and that 'they currently suffer from an asbestos-related disease' were significantly associated with the increased odds of symptoms of probable anxiety [ respectively. All these associations with symptoms of probable anxiety were also significant when considering the 'self-perception of future asbestos-related diseases' (table 3, model 2).
Self-assessment of the intensity of asbestos exposure, the opinions that 'they currently suffer from an asbestos-related disease' and that 'all subjects exposed to asbestos will develop a disease' were significantly associated with increased odds of symptoms of probable depression [ 
Discussion
Three main results emerged from this study. First, this study confirms that a sizeable proportion of person occupationally exposed to asbestos were likely to develop symptoms of probable anxiety and depression (19.7% and 9.9%, respectively). Second, selfassessment of the intensity of asbestos exposure was associated with increased odds of developing anxious and depressive symptoms. Third, the risk to develop anxious and depressive symptoms appeared to be strongly associated with the asbestos-risk perception and self-perception of asbestos-related diseases. This last result confirms that risk perception is a crucial factor affecting attitudes and opinions about health. [14] [15] [16] This multicentre and observational study concerned a large population of French asbestos exposed workers, included in the screening follow up program 6 years ago. Four regions in French are concerned by the study. The present study used a validated scale (HADS) with accurate classification of subscales to assess anxious and depressive symptoms (HADS-A and HADS-D). The intensity of asbestos-exposure was both self-evaluated and evaluated by industrial hygienists and this study was also based on a theoretical model of risk perception. The results obtained here should be stronger according to the arguments listed above. The overall prevalence of symptoms of probable anxiety observed in this study (19.7% ) is very close to the prevalence of abnormal psychological distress among a sub-sample of the asbestos-exposed subjects of ARDCO in the Normandy region (21.1% and 20.6%), previously reported by Maurel et al., 28 and Paris et al., 35 respectively. These previous studies were based on the Psychological Consequences Questionnaires (PCQ), 28, 35 a questionnaire initially designed to assess distress associated with breast cancer screening radiology. The present study, using a validated and better suited questionnaire to measure symptoms of anxiety, confirms the existence and the extent of this negative impact associated with occupational asbestos exposure. These similar results could also be explained by the fact that these previous studies concerned two of the four regions of the ARDCO (namely the Normandy regions) included in the present study, although the prevalence of anxious symptoms was fairly different in the other two regions. To date, only a few studies have evaluated anxious and depressive symptoms among asbestos post-exposure subjects, but using different scale as us. A Chinese study showed that the prevalence of anxiety disorder and depressive symptoms were 14.5% and 20.6%, respectively, among subjects with past exposure to several occupational dusts (silica, cement, coal and asbestos). However, in this Chinese study, anxiety and depression were measured by the Chinese version of the 15-item Geriatric Depression scale, GDS) 36 which differs from the HAD Scale. In a study conducted in Finnish asbestos-exposed workers, Vierikko found that health anxiety, as assessed by the health anxiety inventory, was significantly lower after screening. 37 In former asbestos miners and residents of the mining town included in a radiographic screening program, no difference in mental health status, as assessed by SF12, was reported between subjects with or without radiographic abnormalities. However, in this study, asbestos-exposed subjects had poorer mental health compared with a random sample of the local population.
38 It therefore appears difficult to compare the prevalence of anxiety and depression in these studies, which used various evaluation scales. However, our study is the first to report anxious and depressive symptoms in a large asbestos post-exposed population, using a widely used scale. Among participants of our study, the prevalence of symptoms of probable anxiety (34.8% and 19.0%, respectively, in women and men, table 1) and depression (18.5% and 9.5%, respectively, in women and men, table 2) was higher compared with the French general population of the same age (20.4% and 10.6%, respectively, in women and men for anxiety, 14.4% and 8.4%, respectively, in women and men for mood disorders). 39 A significant regional variation of the prevalence of anxious symptoms was observed (P = 0.0007, table 1). The 2006 Behavioural Risk Factor Surveillance Survey in USA found a regional variation of the prevalence of a lifetime diagnosis of depression (range: from 6.8% to 21.3%) and a lifetime diagnosis of anxiety (range: from 5.4% to 17.2%). 40 The intensity of asbestos exposure was both self-assessed and assessed by the experts. Only self-assessment of the intensity of asbestos exposure was significantly associated with increased odds Table 3 Odds ratio of developing anxious and depressive symptoms, by asbestos exposure, asbestos-risk perception, self-perception of current (model 1) or future (model 2) asbestos-related diseases (multivariate models, n = 2225) of developing anxious and depressive symptoms after adjustment for gender, age, region, last job category in career and smoking status (table 3) . This finding suggests that subjective evaluation of asbestos exposure is likely more anxious and depressive than asbestos exposure assessed by experts. It is noteworthy that most respondents underestimated the intensity of personal exposure to asbestos compared with the hygienist's assessment. 28 The self-assessment of the intensity of asbestos exposure was significantly associated with increased odds of developing anxious and depressive symptoms, independently of self-perception of current or future asbestosrelated diseases. A previous study found that psychological distress was independently associated to self-assessment of the intensity of asbestos exposure, without precision of the nature of that distress. 28 Moreover, among retired Chinese factory workers, to be in the highest asbestos exposure group was significantly associated with increased odds of developing depression [6. This lack of significance of the association between intensity of exposure and anxiety may be due to the small sample size of the study population (n = 359 subjects). 36 The risks of developing anxious and depressive symptoms were also significantly associated to the perception of the asbestos-risk in multivariate analysis. In particular, thinking that 'all subjects exposed to asbestos will develop a disease' was significantly associated with increased odds of developing anxious symptoms (table 3, models 1 and 2). In relation with asbestos exposure, the self-perception of current or future asbestos-related diseases was also significantly associated with increased odds of developing anxious and depressive symptoms (table 3, models 1 and 2). In particular, ignorance of current asbestos-related diseases status was significantly associated with increased odds of developing anxiety and depression (table 3, model 1), as reported by Maurel et al. 28 These observations suggest that delivering specific and clear information to asbestosexposed subjects about asbestos-related diseases may reduce the risk of developing psychological distress. Accordingly, Vierikko found that health anxiety was significantly reduced in both the negative and false-positive groups immediately after screening. 37 Conversely, Paris et al. 35 found no significant effect associated with a counselling visit with a physician after CT screening in 832 former asbestos workers. Consequently, the possible effects of delivering information to such populations need to be studied in more detail.
Some limitations of this study need to be discussed. First, the rate of participation was medium (51, 3%), but comparison between participants subjects and non-participants found only difference for region of recruitment and asbestos exposure according to expert's assessment. However, asbestos expert's assessment was not associated to anxious and depressive symptoms (tables 1 and 2) .
Second, the study population may not be representative of all French asbestos exposed workers. Subjects were volunteers to participate to the study, and they may therefore have been more anxious and depressive than the rest of French asbestos exposed workers. However, this study included four regions in France which are among the most concerned by the occupational asbestos exposure. The fact that the results obtained in this study were concordant with those observed in the previous study in Normandy region minimises the effect of the type of participants' selection. Third, we were not able to include a control group in the present study. Indeed, subjects included in this longitudinal study were selected on the basis of their participation to a CT scan longitudinal survey. Therefore, only subjects with substantial asbestos exposure according to expert's assessment were invited to participate on the longitudinal study. . A previously published study among subjects from Normandy region, prior to CT scan, comprised a control group, but used less validated scale of anxiety. This study found similar results, particularly the association between psychological distress and self-perception of asbestos exposure and the risk of current or future disease related to asbestos exposure. 28 Finally, we did not include in the final model the asbestos related diseases. According to Pairon et al., 11 <1% of this cohort (in men) had lung cancer at the 6-year follow-up and <0.7% had asbestosis.
Conclusion
The results of this large observational study confirm that previously asbestos-exposed subjects are more likely to develop anxious and depressive symptoms. According to our results, anxious and depressive symptoms were significantly associated with selfassessment of the intensity of asbestos exposure, perception of the asbestos-risk and self-perception of asbestos-related diseases. Future studies should assess the effect of providing information to asbestosexposed subjects about asbestos-related diseases. It would also be interesting to use more general scales measuring emotional, social components to assess the overall impact on health and quality of life of asbestos-exposed subjects. The results of the present study should be taken into account in the prevention of anxiety and depression among asbestos-exposed workers.
Supplementary data
Supplementary data are available at EURPUB online.
